ZR2 Bioenergy Ltd
Incorporated in 1939, ZR2 Bioenergy Limited is in the business of Ethanol and bioenergy products.[1]
- Market Cap ₹ 102 Cr.
- Current Price ₹ 285
- High / Low ₹ 456 / 255
- Stock P/E 237
- Book Value ₹ 392
- Dividend Yield 0.04 %
- ROCE 0.21 %
- ROE 0.09 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.73 times its book value
Cons
- Company has a low return on equity of 0.28% over last 3 years.
- Working capital days have increased from -2,175 days to 169 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.16 | 0.00 | 1.57 | 1.49 | 0.00 | |
| 0.53 | 0.67 | 0.63 | 0.72 | 0.59 | 0.63 | 0.73 | 0.14 | 1.11 | 0.25 | 1.46 | 1.86 | 0.83 | |
| Operating Profit | -0.53 | -0.67 | -0.63 | -0.72 | -0.59 | -0.63 | -0.73 | -0.14 | 0.05 | -0.25 | 0.11 | -0.37 | -0.83 |
| OPM % | 4.31% | 7.01% | -24.83% | ||||||||||
| 0.41 | 0.36 | 4.02 | 0.35 | 0.29 | 0.26 | 0.75 | 0.23 | 0.27 | 0.29 | 0.46 | 0.62 | 1.44 | |
| Interest | 0.05 | 0.07 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.19 | 0.01 | 0.00 |
| Depreciation | 0.06 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.07 |
| Profit before tax | -0.23 | -0.46 | 3.31 | -0.46 | -0.38 | -0.46 | -0.05 | 0.09 | 0.32 | 0.03 | 0.38 | 0.20 | 0.54 |
| Tax % | -4.35% | 0.00% | 41.39% | 2.17% | 0.00% | 0.00% | 0.00% | 0.00% | -21.88% | 0.00% | 0.00% | 55.00% | |
| -0.22 | -0.46 | 1.94 | -0.46 | -0.38 | -0.46 | -0.05 | 0.09 | 0.39 | 0.04 | 0.39 | 0.08 | 0.43 | |
| EPS in Rs | -1.38 | -2.88 | 12.12 | -2.88 | -2.38 | -2.88 | -0.31 | 0.56 | 2.44 | 0.25 | 1.09 | 0.22 | 1.21 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 9% |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 20% |
| 3 Years: | -44% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 109% |
| 3 Years: | 69% |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 1% |
| 3 Years: | 0% |
| Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.36 | 0.36 | 0.36 |
| Reserves | 3.59 | 3.11 | 5.06 | 4.59 | 4.21 | 3.76 | 3.69 | 3.80 | 4.18 | 4.21 | 16.50 | 138.98 | 139.56 |
| 0.57 | 0.00 | 0.00 | 0.10 | 0.00 | 0.14 | 0.00 | 0.00 | 0.00 | 12.01 | 22.01 | 0.00 | 0.00 | |
| 0.19 | 0.15 | 0.46 | 0.10 | 0.11 | 0.09 | 0.03 | 0.10 | 0.22 | 0.05 | 0.41 | 0.14 | 0.58 | |
| Total Liabilities | 4.51 | 3.42 | 5.68 | 4.95 | 4.48 | 4.15 | 3.88 | 4.06 | 4.56 | 16.43 | 39.28 | 139.48 | 140.50 |
| 0.53 | 0.44 | 0.35 | 0.27 | 0.18 | 0.11 | 0.03 | 0.03 | 0.03 | 0.03 | 0.01 | 0.50 | 0.48 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 118.90 | 119.57 |
| Investments | 0.10 | 0.10 | 0.10 | 0.05 | 0.04 | 0.02 | 0.00 | 0.00 | 0.00 | 0.23 | 0.26 | 0.10 | 0.10 |
| 3.88 | 2.88 | 5.23 | 4.63 | 4.26 | 4.02 | 3.85 | 4.03 | 4.53 | 16.17 | 39.01 | 19.98 | 20.35 | |
| Total Assets | 4.51 | 3.42 | 5.68 | 4.95 | 4.48 | 4.15 | 3.88 | 4.06 | 4.56 | 16.43 | 39.28 | 139.48 | 140.50 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | -0.50 | 3.30 | -0.88 | -0.56 | -0.66 | -2.06 | 0.26 | 0.91 | -11.34 | -19.78 | 31.00 | |
| 0.00 | -0.03 | 0.21 | 0.33 | 0.67 | 0.51 | 2.72 | -0.56 | 0.19 | -1.66 | 2.28 | -116.69 | |
| 0.25 | -0.64 | 0.00 | 0.10 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 12.00 | 21.49 | 100.39 | |
| Net Cash Flow | 0.25 | -1.16 | 3.51 | -0.45 | 0.10 | -0.15 | 0.66 | -0.30 | 1.10 | -1.01 | 3.98 | 14.70 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 371.29 | 432.42 | 0.00 | |||||||||
| Inventory Days | 0.00 | 0.00 | 0.00 | |||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 371.29 | 432.42 | 0.00 | |||||||||
| Working Capital Days | 361.85 | -4,519.49 | 169.03 | |||||||||
| ROCE % | -4.21% | -11.07% | -9.66% | -8.94% | -8.46% | -10.68% | -3.29% | 2.30% | 7.71% | 0.10% | 1.27% | 0.21% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Nov - Submission of Newspaper Advertisement issued for the publication of Unaudited (Standalone and Consolidated) Financial Results for the quarter ended September 30, 2025
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Nov - Submission of Newspaper Advertisement issued for the publication of Unaudited (Standalone and Consolidated) Financial Results for the quarter ended September 30, 2025
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
14 Nov - Crisil MA flagged Rs18.50 crore short-term deposit with NBFC; monitoring report for Sept 30, 2025.
-
Unaudited (Standalone And Consolidated) Financial Result Of The Company For The Quarter And Half Year Ended September 30 2025 Pursuant To Regulation 33 Of SEBI (LODR) Regulation 2015
14 Nov - Board approved Sep 30, 2025 results; 61% acquisition on Dec 31, 2024; PAT ₹27.08 lakh.
-
Board Meeting Outcome for Pursuant To Regulation 30 Of SEBI (LODR) Regulation, 2015: Outcome Of Board Meeting Held On November 14, 2025
14 Nov - Unaudited Q2 Sep 30, 2025: standalone profit ₹27.08L; H1 profit ₹57.94L; CWIP ₹11,956.88L.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
ZR2BEL is in the business of bioenergy and the waste-to-energy economy, and produces
biofuels, hydrogen and electricity, carbon credits and other derivative products from agri waste, biomass, sugar cane, grain, corn, maize, waste and RDF.